151 related articles for article (PubMed ID: 7705677)
1. Activated (HLA-DR+) T-lymphocyte subsets in cervical carcinoma and effects of radiotherapy and immunotherapy with sizofiran on cell-mediated immunity and survival.
Miyazaki K; Mizutani H; Katabuchi H; Fukuma K; Fujisaki S; Okamura H
Gynecol Oncol; 1995 Mar; 56(3):412-20. PubMed ID: 7705677
[TBL] [Abstract][Full Text] [Related]
2. [Electron microscopic and immunological studies concerning the effect on the antitumor activity of sizofiran (SPG) combined with radiotherapy for cervical cancer].
Hasegawa K; Nishimura R; Kinugasa M; Okamura M; Kimura A; Ohtsu F; Takeuchi K; Mizuhira V
Nihon Gan Chiryo Gakkai Shi; 1990 Oct; 25(10):2549-61. PubMed ID: 2124607
[TBL] [Abstract][Full Text] [Related]
3. Effect of blood transfusion during radiotherapy on the immune function of patients with cancer of the uterine cervix: role of interleukin-10.
Santin AD; Bellone S; Palmieri M; Bossini B; Dunn D; Roman JJ; Pecorelli S; Cannon M; Parham GP
Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1345-55. PubMed ID: 12459356
[TBL] [Abstract][Full Text] [Related]
4. Immunologic Monitoring of T-Lymphocyte Subsets and Hla-Dr-Positive Monocytes in Kidney Transplant Recipients: A Prospective, Observational Cohort Study.
Cho JH; Yoon YD; Jang HM; Kwon E; Jung HY; Choi JY; Park SH; Kim YL; Kim HK; Huh S; Won DI; Kim CD
Medicine (Baltimore); 2015 Nov; 94(44):e1902. PubMed ID: 26554788
[TBL] [Abstract][Full Text] [Related]
5. [The study on the immunological effect of sizofilan combined with radiotherapy in patients with uterine cervical cancer].
Sekiguchi I; Suzuki M; Izumi A; Aida I; Tamada T
Nihon Gan Chiryo Gakkai Shi; 1990 Nov; 25(11):2659-64. PubMed ID: 2126027
[TBL] [Abstract][Full Text] [Related]
6. [Improvement in the effects of radiation therapy with BRM].
Inomata T; Ogawa Y; Nishioka A; Maeda T; Seguchi H
Gan No Rinsho; 1990 Oct; 36(13):2278-85. PubMed ID: 2123503
[TBL] [Abstract][Full Text] [Related]
7. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
[TBL] [Abstract][Full Text] [Related]
8. During HIV infection, CD4+ CD38+ T-cells are the predominant circulating CD4+ subset whose HLA-DR positivity increases with disease progression and whose V beta repertoire is similar to that of CD4+ CD38- T-cells.
Ramzaoui S; Jouen-Beades F; Gilbert D; Borsa-Lebas F; Michel Y; Humbert G; Tron F
Clin Immunol Immunopathol; 1995 Oct; 77(1):33-41. PubMed ID: 7554481
[TBL] [Abstract][Full Text] [Related]
9. [The cytoimmunological effect of concomitant use of sizofiran (SPG) on advanced uterine cervical cancer treated with radiation].
Iwanari O; Miyako J; Ryuko K; Date Y; Moriyama M; Moriyama M; Kijima S; Yoshino N; Kitao M
Nihon Gan Chiryo Gakkai Shi; 1989 Oct; 24(10):2355-61. PubMed ID: 2533231
[TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of sizofilan as assistant immunotherapy in treatment of head and neck cancer.
Kimura Y; Tojima H; Fukase S; Takeda K
Acta Otolaryngol Suppl; 1994; 511():192-5. PubMed ID: 7911266
[TBL] [Abstract][Full Text] [Related]
11. Immunological modulation of lymphocyte subpopulation in cervical cancer tissue by sizofiran and OK-432.
Gorai I; Yanagibashi T; Minaguchi H
Gynecol Oncol; 1992 Feb; 44(2):137-46. PubMed ID: 1371977
[TBL] [Abstract][Full Text] [Related]
12. Dominant enrichment of phenotypically activated CD38(+) HLA-DR(+) CD8(+) T cells, rather than CD38(+) HLA-DR(+) CD4(+) T cells, in HIV/HCV coinfected patients on antiretroviral therapy.
d'Ettorre G; Ceccarelli G; Serafino S; Giustini N; Cavallari EN; Bianchi L; Pavone P; Bellelli V; Turriziani O; Antonelli G; Stroffolini T; Vullo V
J Med Virol; 2016 Aug; 88(8):1347-56. PubMed ID: 26765625
[TBL] [Abstract][Full Text] [Related]
13. Adoptive transfer of ex vivo-activated memory T-cell subsets with cyclophosphamide provides effective tumor-specific chemoimmunotherapy of advanced metastatic murine melanoma and carcinoma.
Gold JE; Zachary DT; Osband ME
Int J Cancer; 1995 May; 61(4):580-6. PubMed ID: 7759164
[TBL] [Abstract][Full Text] [Related]
14. [T-lymphocyte immune in HIV-infected people and AIDS patients in China].
Li T; Qiu Z; Wang A; Sheng R
Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1391-5. PubMed ID: 12509921
[TBL] [Abstract][Full Text] [Related]
15. Augmenting effect of sizofiran on the immunofunction of regional lymph nodes in cervical cancer.
Shimizu Y; Hasumi K; Masubuchi K
Cancer; 1992 Mar; 69(5):1184-94. PubMed ID: 1739919
[TBL] [Abstract][Full Text] [Related]
16. Effects of concurrent cisplatinum administration during radiotherapy vs. radiotherapy alone on the immune function of patients with cancer of the uterine cervix.
Santin AD; Hermonat PL; Ravaggi A; Bellone S; Roman J; Pecorelli S; Cannon M; Parham GP
Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):997-1006. PubMed ID: 11072156
[TBL] [Abstract][Full Text] [Related]
17. Effects of concomitant use of doxifluridine, radiotherapy and immunotherapy in patients with advanced cervical cancer.
Yamamoto K; Noda K; Hatae M; Kudo T; Hasegawa K; Nishimura R; Honjo H; Yajima A; Sato S; Mizutani K; Yakushiji M; Terashima Y; Ochiai K; Sasaki H; Ozaki M
Oncol Rep; 2001; 8(2):273-7. PubMed ID: 11182039
[TBL] [Abstract][Full Text] [Related]
18. [Pathogenetic and clinical significance of peripheral activated T-lymphocyte subsets in Basedow's disease].
Wenjuan D; Shen G; Ye W
Schweiz Med Wochenschr; 1992 May; 122(21):800-4. PubMed ID: 1604285
[TBL] [Abstract][Full Text] [Related]
19. [Change of T lymphocyte and its activated subsets in SARS patients].
Yu XY; Zhang YC; Han CW; Wang P; Xue XJ; Cong YL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Oct; 25(5):542-6. PubMed ID: 14650154
[TBL] [Abstract][Full Text] [Related]
20. [Study on the changes of the T-lymphocyte subsets and their significance in influenza A (H1N1) virus patients].
Zhang SP; Zhu ML; Yu JH; Wang Y; Lou GQ
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Jun; 24(3):181-3. PubMed ID: 21186520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
